International Journal of Pharmaceutical Investigation, 2018, 8, 1, 50-52.
DOI: 10.4103/jphi.JPHI_14_18
Published: July 2018
Type: Letter to Editor
Authors:
Jasjeet Kaur Narang
Department of Pharmaceutics, Khalsa College of Pharmacy, Amritsar, Punjab, India.
Ramandeep Singh Narang
Department of Oral and Maxillofacial Pathology, Sri Guru Ram Das Institute of Dental Sciences and Research, Amritsar, Punjab, India.
Balwinder Singh
Department of Oral Medicine, Sri Guru Ram Das Institute of Dental Sciences and Research, Amritsar, Punjab, India.
Sukhdeep S. Kahlon
Department of Orthodontics, Sri Guru Ram Das Institute of Dental Sciences and Research, Amritsar, Punjab, India.
Jiji George
Department of Oral Pathology, B.B.D Dental College, Lucknow, Uttar Pradesh, India.
Anmol Dogra
Department of Pharmaceutics, Khalsa College of Pharmacy, Amritsar, Punjab, India.
ABSTRACT
Dear Sir,
Candida, a type of fungus, can cause infections, which can be either local or systemic. The human body hosts small amounts of this fungus under normal conditions. However, problems arise when it begins to multiply and creates an overgrowth. Although more than 150 species of Candida exist, the majority of infections are caused by a species called Candida albicans. The prognosis for candida infections is often very good. In general, the condition is not serious and can be easily treated.[1]
The majority of synthetic therapeutic agents used to treat candida infections suffer from various disadvantages such as they are toxic, expensive, and have to be administered frequently.[2] To overcome the drawbacks of synthetic antifungal agents, the use of plant‑derived products as disease control agents has been explored. Read more…
Keywords: Nil.